Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 2,277,953	$ 8,715,279
Marketable securities	4,430,384	0
Accounts receivable, net	912,399	693,717
Prepaid expenses and other current assets	767,430	443,872
Inventories	2,038,298	1,792,335
Advances on contracts	1,154,826	1,325,301
Total current assets	11,581,290	12,970,504
Furniture, fixtures and equipment, net	15,333	18,146
Intangibles, net	214,742	227,956
Right of use assets finance lease	15,483	17,645
Right of use assets operating lease	422,355	443,685
Other assets	24,150	24,150
Total assets	12,273,353	13,702,086
Current liabilities:
Accrued expenses and other payables	1,032,532	1,124,839
Accrued expenses, related party	240,830	167,549
Current portion of finance lease liabilities	9,582	9,365
Current portion of operating lease liabilities	94,532	91,701
Total current liabilities	2,652,955	3,299,675
Non-current portion of finance lease liabilities	8,219	10,698
Non-current portion of operating lease liabilities	360,304	385,279
Total liabilities	3,021,478	3,695,652
Commitments
Stockholders’ equity
Common stock, par value $.001; authorized 100,000,000 shares; 69,805,700 shares issued and 69,772,367 shares outstanding as of March 31, 2023; shares; 69,306,497 shares issued and 69,273,164 shares outstanding as of December 31, 2022;	69,806	69,306
Additional paid in capital	128,042,597	127,478,325
Accumulated deficit	(117,718,071)	(116,410,405)
Treasury stock, at cost, 33,333 shares	(911,516)	(911,516)
Total Milestone Scientific, Inc. stockholders' equity	9,482,816	10,225,710
Noncontrolling interest	(230,941)	(219,276)
Total stockholders’ equity	9,251,875	10,006,434
Total liabilities and stockholders’ equity	12,273,353	13,702,086
Nonrelated Party [Member]
Current liabilities:
Accounts payable	823,907	1,102,729
Related Party [Member]
Current liabilities:
Accounts payable	$ 451,572	$ 803,492